Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.

ABSTRACT:

Background

Evidence around prevalence of bacterial coinfection and pattern of antibiotic use in COVID-19 is controversial although high prevalence rates of bacterial coinfection have been reported in previous similar global viral respiratory pandemics. Early data on the prevalence of antibiotic prescribing in COVID-19 indicates conflicting low and high prevalence of antibiotic prescribing which challenges antimicrobial stewardship programmes and increases risk of antimicrobial resistance (AMR).

Aim

To determine current prevalence of bacterial coinfection and antibiotic prescribing in COVID-19 patients.

Data source

OVID MEDLINE, OVID EMBASE, Cochrane and MedRxiv between January 2020 and June 2021.

Study eligibility

English language studies of laboratory-confirme

SUBMITTER: Alshaikh FS 

PROVIDER: S-EPMC9342726 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature